Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial

被引:5
|
作者
Kim, Jaehwan [1 ,2 ,3 ]
Lee, Jongmi [1 ]
Hawkes, Jason E. [2 ]
Li, Xuan [1 ]
Kunjravia, Norma [1 ]
Rambhia, Darshna [1 ]
Cueto, Inna [1 ]
Moreno, Ariana [1 ]
Hur, Hong [4 ]
Garcet, Sandra
Zhou, Wei [5 ]
Cao, Junyue [5 ]
Krueger, James G. [1 ]
机构
[1] Rockefeller Univ, Lab Invest Dermatol, 1230 York Ave, New York, NY 10065 USA
[2] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA
[3] Vet Affairs Northern Calif Hlth Care Syst, Dermatol Sect, Mather, CA USA
[4] Rockefeller Univ, Ctr Clin & Translat Sci, Res Bioinformat, New York, NY 10065 USA
[5] Rockefeller Univ, Lab Single Cell Genom & Populat Dynam, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
dendritic cells; gene expression; IL-17; mild-to-moderate disease; psoriasis; secukinumab; type 17 T cells; T cells;
D O I
10.1016/j.jaad.2022.04.060
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:428 / 430
页数:3
相关论文
共 50 条
  • [1] A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
    Seethamraju, Harish
    Yang, Otto O.
    Loftus, Richard
    Ogbuagu, Onyema
    Sammartino, Daniel
    Mansour, Ali
    Sacha, Jonah B.
    Ojha, Sohita
    Hansen, Scott G.
    Arman, Arvin Cyrus
    Lalezari, Jacob P.
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 891 - 899
  • [2] Efficacy and Safety of Jueyin Granules for Patients with Mild-to-Moderate Psoriasis Vulgaris: Protocol for a Multicenter Randomized Placebo-Controlled Trial
    Li, Su
    Zhang, Cang
    Zhang, Hong-Ya
    Zhou, Meng
    Wang, Si-Nong
    Xu, Rong
    Zhou, Dong-Mei
    Ji, Yun-Run
    Lv, Jing-Jing
    Yin, Qing-Feng
    Wang, Rui-Ping
    Li, Wei
    Liu, Yan-Ping
    Wang, Jian-Feng
    Li, Bin
    Li, Xin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [3] ACUPUNCTURE FOR THE TREATMENT OF MILD OR MODERATE ASTHMA: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
    Bilgin, Gulden
    Arslan, Huseyin
    Balci, Nurgul
    Sunay, Didem
    NOBEL MEDICUS, 2016, 12 (02): : 31 - 37
  • [4] Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Dubois, Bruno
    Lopez-Arrieta, Jesus
    Lipschitz, Stanley
    Triantafyllos, Doskas
    Spiru, Luiza
    Moroz, Svitlana
    Venger, Olena
    Vermersch, Patrick
    Moussy, Alain
    Mansfield, Colin D. D.
    Hermine, Olivier
    Tsolaki, Magda
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [5] Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López-Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [6] PLACEBO-CONTROLLED TRIAL OF FELODIPINE IN PATIENTS WITH MILD-TO-MODERATE HEART-FAILURE
    LITTLER, WA
    SHERIDAN, DJ
    BRITISH HEART JOURNAL, 1995, 73 (05): : 428 - 433
  • [7] Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López‑Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [8] A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease
    Henderson, Samuel T.
    Morimoto, Bruce H.
    Cummings, Jeffrey L.
    Farlow, Martin R.
    Walker, Judith
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 547 - 557
  • [9] The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
    Alireza Yargholi
    Leila Shirbeigi
    Roja Rahimi
    Parvin Mansouri
    Mohammad Hossein Ayati
    BMC Research Notes, 14
  • [10] The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
    Yargholi, Alireza
    Shirbeigi, Leila
    Rahimi, Roja
    Mansouri, Parvin
    Ayati, Mohammad Hossein
    BMC RESEARCH NOTES, 2021, 14 (01)